Citigroup’s Dermira, Inc. DERM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-18,648
Closed -$283K 7923
2019
Q4
$283K Buy
18,648
+12,433
+200% +$107K ﹤0.01% 4897
2019
Q3
$39K Sell
6,215
-15,473
-71% -$129K ﹤0.01% 6296
2019
Q2
$207K Buy
21,688
+3,963
+22% +$42.7K ﹤0.01% 5239
2019
Q1
$240K Sell
17,725
-57,547
-76% -$480K ﹤0.01% 4923
2018
Q4
$542K Buy
75,272
+67,768
+903% +$741K ﹤0.01% 4039
2018
Q3
$81K Buy
7,504
+4,317
+135% +$43.5K ﹤0.01% 6103
2018
Q2
$30K Buy
3,187
+2,793
+709% +$26K ﹤0.01% 6699
2018
Q1
$3K Sell
394
-135
-26% -$2.94K ﹤0.01% 7327
2017
Q4
$15K Sell
529
-17,082
-97% -$453K ﹤0.01% 6880
2017
Q3
$475K Buy
17,611
+17,414
+8,840% +$456K ﹤0.01% 4174
2017
Q2
$6K Buy
197
+43
+28% +$1.31K ﹤0.01% 6719
2017
Q1
$5K Sell
154
-5,237
-97% -$169K ﹤0.01% 6825
2016
Q4
$163K Buy
5,391
+5,291
+5,291% +$171K ﹤0.01% 5456
2016
Q3
$3K Hold
100
﹤0.01% 6891
2016
Q2
$3K Sell
100
-84,350
-100% -$2.33M ﹤0.01% 6894
2016
Q1
$1.75M Buy
84,450
+1,551
+2% +$38.1K ﹤0.01% 2661
2015
Q4
$2.87M Buy
82,899
+1,480
+2% +$42.5K ﹤0.01% 2200
2015
Q3
$1.9M Buy
81,419
+81,222
+41,229% +$1.97M ﹤0.01% 2484
2015
Q2
$4K Sell
197
-230
-54% -$3.55K ﹤0.01% 6925
2015
Q1
$7K Sell
427
-912
-68% -$15.3K ﹤0.01% 6632
2014
Q4
$24K Buy
+1,339
New +$22.4K ﹤0.01% 6134

Citigroup's DERM Position: Q1 2020 in Review

Citigroup sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 18,648 shares — an estimated $283K sold.

Citigroup first reported a position in DERM in Q4 2014 and held it in 21 quarters. The position peaked at $2.87M in Q4 2015. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.

  • Citigroup reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
  • Citigroup sold 18,648 Dermira, Inc. shares in Q1 2020, an estimated $283K.
  • Citigroup first reported a position in Dermira, Inc. in Q4 2014 and held it in 21 quarters.
  • Citigroup's Dermira, Inc. position peaked at $2.87M in Q4 2015.
  • 0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.

Based on Citigroup's 13F filing for Q1 2020, filed 12 May 2020.